New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 30, 2014
09:13 EDTA, MRKDako, Merck to collaborate on companion diagnostic test
Dako, an Agilent Technologies (A) company and a worldwide provider of cancer diagnostics, announced a collaboration with Merck (MRK) to develop a companion diagnostic test for the analysis of the potential tumor biomarker PD-L1 to aid in the treatment of cancer. The companion diagnostic test coming out of this collaboration will be evaluated as part of the clinical development program for Merck & Co.'s investigational anti-PD-1 antibody being studied for the treatment of cancer. The financial terms of the development and commercialization agreement were not disclosed.
News For A;MRK From The Last 14 Days
Check below for free stories on A;MRK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 18, 2014
07:57 EDTMRKCambridge Healthtech Institute to hold a summit
6th Annual Bioprocessing Summit to be held in Boston on August 18-22.
August 14, 2014
16:09 EDTAAgilent sees FY14 EPS $3.04-$3.08, consensus $3.07
Sees FY14 revenue $6.99B-$7.03B, consensus $6.99B
16:08 EDTAAgilent sees Q4 EPS 87c-91c, consensus 94c
Subscribe for More Information
16:06 EDTAAgilent reports Q3 EPS 78c, consensus 74c
Subscribe for More Information
15:03 EDTANotable companies reporting after market close
Subscribe for More Information
August 13, 2014
18:02 EDTMRKMerck provides statement on role of PNEUMOVAX 23 in updated ACIP recommendations
Subscribe for More Information
16:52 EDTMRKMerck confirms FDA approval of BELSOMRA
Subscribe for More Information
15:30 EDTMRKFDA approves Belsomra sleep drug
The Food and Drug Administration approved Belsomra tablets for use as needed to treat difficulty in falling and staying asleep. Belsomra is an orexin receptor antagonist and is the first approved drug of this type. Belsomra will be dispensed with an FDA-approved patient Medication Guide that provides instructions for its use and important safety information. Belsomra is a controlled substance because it can be abused or lead to dependence. Belsomra is made by Merck, Sharpe & Dohme.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use